Top Markets
#1 Black Phoenix Black Phoenix +828.65%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +29.24%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.47%
#4 Beam Beam +25.79%
#5 SAFEcoin SAFEcoin +20.83%
#6 pipedog pipedog +20.78%
#7 Magma Finance Magma Finance +20.28%
#8 Bless Bless +17.45%
#9 PondCoin PondCoin +17.06%
#10 THORChain THORChain +15.98%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Voronoi, Inc. Voronoi, Inc.

Voronoi, Inc.

310210
Rank in Stocks #6294
Voronoi, Inc., founded in 2015 and based in Incheon, South Korea, is a... Voronoi, Inc., founded in 2015 and based in Incheon, South Korea, is a biotechnology company dedicated to the research, development, and identification of small molecule kinase inhibitors. Its extensive product pipeline addresses various medical needs. Key candidates include VRN01, an oral leucine-rich repeat kinase 2 (LRRK2) inhibitor, being developed for glioblastoma multiforme, brain cancer, and pancreatic cancer. Treatments for lung cancer are represented by VRN07, VRN06, and VRN11, while VRN08 and VRN10 are in development for breast cancer. Additionally, VRN02 targets rheumatoid arthritis and atopic dermatitis. The company's pipeline further encompasses VRN04-1 for autoimmune conditions, VRN04-2 for multiple sclerosis and amyotrophic lateral sclerosis (ALS), VRN13 for pulmonary arterial hypertension, and VRN14 for challenging solid tumors.
Share Price
$115.48
Market Cap
$2.12B
Change (1 day)
0.72%
Change (1 year)
29.38%
Country
KR
Trade Voronoi, Inc. (310210)

Category

Healthcare
Operating Margin for Voronoi, Inc. (310210)
Operating Margin as of 2026 TTM: 0.00%
According to Voronoi, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Voronoi, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.